RCT of Zhi Byed 11 (ZB11) Versus Misoprostol in Tibet

NACompletedINTERVENTIONAL
Enrollment

848

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

March 31, 2007

Conditions
Hemorrhage
Interventions
DRUG

Zhi Byed 11

Trial Locations (3)

Unknown

Lhasa Maternal-Child Health (MCH) Hospital, Lhasa

Lhasa Municipal Hospital, Lhasa

The Mentzikhang Traditional Tibetan Medicine and Astrology Hospital, Lhasa

All Listed Sponsors
collaborator

Global Network for Women's and Children's Health Research

OTHER

collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Fogarty International Center of the National Institute of Health

NIH

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

collaborator

National Cancer Institute (NCI)

NIH

collaborator

RTI International

OTHER

collaborator

University of Utah

OTHER

collaborator

Health Bureau Tibet Autonomous Region

UNKNOWN

collaborator

University of California, San Francisco

OTHER

collaborator

One Heart Project

UNKNOWN

lead

NICHD Global Network for Women's and Children's Health

NETWORK

NCT00147420 - RCT of Zhi Byed 11 (ZB11) Versus Misoprostol in Tibet | Biotech Hunter | Biotech Hunter